NEETPGAI
FeaturesBlogComparePricing
Log inStart Free
NEETPGAI

AI-powered NEET PG preparation platform. Master all 19 subjects with adaptive MCQs, AI tutoring, and spaced repetition.

Product

  • Features
  • Subjects
  • Previous Year Questions
  • Compare
  • Pricing
  • Blog

Features

  • Adaptive MCQ Practice
  • AI Tutor
  • Mock Tests
  • Spaced Repetition

Resources

  • Blog
  • Study Guides
  • NEET PG Updates
  • Contact & support

Legal

  • Privacy Policy
  • Terms of Service

Stay updated

© 2026 NEETPGAI. All rights reserved.
    PYQs/2020/Q74
    Verified answer (AI cross-checked + SME reviewed)

    Q74 (2020, Gynecology) — Correct answer: C. Point A is 2 cm above the external os and 5cm lateral to the internal uterine canal.

    NEET PG 2020
    Q74
    baby OBG
    Gynecology
    tier-3 (2/3 verifier agreement)

    A 52 year old woman diagnosed with carcinoma cervix stage 2B was advised radiotherapy. Which of the following statements regarding radiotherapy is false ?

    A. Point B receives a dose of 6000 cGy
    B. Point A receives a dose of 7000 cGy
    C. Point A is 2 cm above the external os and 5cm lateral to the internal uterine canal
    D. Point B is 3 cm lateral to point A

    Correct Answer: C. Point A is 2 cm above the external os and 5cm lateral to the internal uterine canal

    The question asks which statement about radiotherapy dosimetry in cervical cancer is FALSE. Option C contains the incorrect anatomical definition of Point A. The Manchester system (gold standard for brachytherapy dose specification in cervical cancer) defines Point A as the reference point located 2 cm lateral to the central canal of the uterus and 2 cm superior to the lateral vaginal fornix (or approximately 2 cm above the external os). The error in option C is the lateral distance: it states "5 cm lateral" when the correct distance is 2 cm lateral. This is a critical distinction because Point A represents the dose to tissues at risk (parametrial tissues, bladder, rectum) and serves as the standard reference for reporting brachytherapy doses in cervical cancer. Point B, by contrast, is located 3 cm lateral to Point A (making it approximately 5 cm from the central canal) and represents the dose to pelvic sidewall tissues. The typical dose prescription in cervical cancer brachytherapy is 7000 cGy to Point A and 6000 cGy to Point B, making options A and B correct. Option D correctly states the 3 cm lateral relationship between Points A and B. Understanding these anatomical landmarks is essential for Indian gynecologists managing cervical cancer, as brachytherapy remains a cornerstone of treatment in resource-limited settings where external beam radiotherapy access may be limited.

    Why the other options are wrong

    A. Point B receives a dose of 6000 cGy — This statement is CORRECT. Point B, located 3 cm lateral to Point A (approximately 5 cm from the central uterine canal), represents the pelvic sidewall dose. The standard dose prescription to Point B in cervical cancer brachytherapy is indeed 6000 cGy. This is a true statement and therefore not the false answer being sought. B. Point A receives a dose of 7000 cGy — This statement is CORRECT. Point A is the primary reference point in the Manchester system for cervical cancer brachytherapy. The standard dose prescription to Point A is 7000 cGy, which represents the dose to parametrial tissues and organs at risk. This is an accurate statement and not the false answer. D. Point B is 3 cm lateral to point A — This statement is CORRECT. The Manchester system defines Point B as being located exactly 3 cm lateral to Point A. This anatomical relationship is fundamental to the dose specification system. Since this is accurate, it cannot be the false statement the question seeks.

    High-Yield Facts

    • Point A (Manchester system): Located 2 cm lateral to the central uterine canal and 2 cm superior to the lateral vaginal fornix; receives 7000 cGy in cervical cancer brachytherapy
    • Point B (Manchester system): Located 3 cm lateral to Point A (≈5 cm from central canal); represents pelvic sidewall dose of 6000 cGy
    • Manchester system is the gold standard for dose specification in cervical cancer brachytherapy, used universally including in Indian cancer centers
    • Common error: Confusing Point A's lateral distance as 5 cm (which is actually Point B's distance from the central canal) — the discriminating fact in this question
    • Brachytherapy advantage: Delivers high doses to tumor while sparing normal tissues; critical in Indian settings where external beam radiotherapy infrastructure may be limited

    Mnemonics

    Point A vs Point B — '2-3-5' Rule Point A: 2 cm lateral, 2 cm superior → receives 7000 cGy. Point B: 3 cm lateral to A → receives 6000 cGy. Total lateral distance of B from canal = 2+3 = 5 cm. Use this when you see lateral distances in cervical cancer brachytherapy questions. Manchester = 'A before B, A closer to uterus' Point A is closer to the uterus (2 cm lateral), Point B is farther (3 cm more lateral). A gets higher dose (7000), B gets lower dose (6000). Remember: A = Anterior/Axis (closer), B = Beyond (farther).

    NBE Trap

    NBE exploits the confusion between Point A's actual lateral distance (2 cm) and Point B's total distance from the central canal (5 cm). Students who memorize "5 cm" without understanding the reference point often select option C, not realizing the question asks for the FALSE statement. The trap is that 5 cm IS a real number in the system—just not for Point A's lateral distance.

    Clinical Pearl

    In Indian tertiary cancer centers, the Manchester system remains the standard for reporting brachytherapy doses in cervical cancer. Accurate knowledge of Point A and B definitions is essential for gynecologists interpreting dose reports and communicating with radiation oncologists, especially in multidisciplinary tumor boards where treatment planning is discussed.

    _Reference: DC Dutta's Textbook of Gynaecology (6th ed.), Ch. 24 (Carcinoma Cervix); Harrison's Principles of Internal Medicine, Ch. 101 (Gynecologic Malignancies)_

    Ask AI Tutor about this question

    Stuck on a distractor? Want a worked-through clinical scenario? The AI Tutor is a NEETPGAI Pro feature — sign up free to practice the full question bank, then unlock the AI Tutor when you're ready.

    Explain this concept in plain language
    Why is each wrong option wrong?
    Give me a clinical scenario where this is tested
    Sign up free Already have an account? Log in

    Free to start, no credit card required. The 3 prompts/day quota is shared with practice + tutor + deep-dive across NEETPGAI.

    Memory-based reconstruction

    NBE does not officially release NEET PG papers per the 2025 Supreme Court directive. This question was reconstructed from 1 community source: PrepLadder NEET PG 2020 Recall PDF. Cross-verified by Claude Haiku 4.5 + Gemini 2.5 Flash + community-aggregate vote, then reviewed by a practising medical SME.

    ← All NEET PG 2020 questionsPractice with AI Tutor →